ProShare Advisors
AXDX

ProShare Advisors’s Accelerate Diagnostics AXDX Stock Holding History

ProShare Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,106
Closed -$288K – 2300
2014
Q2 		$288K Sell
1,106
-15
-1% -$3.27K ﹤0.01% 1938
2014
Q1 		$244K Buy
+1,121
New +$166K ﹤0.01% 2381

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $321M AUM 14.7% 1-Year Est. Return

ProShare Advisors's AXDX Position: Q3 2014 in Review

ProShare Advisors sold out of Accelerate Diagnostics (AXDX) in Q3 2014, closing a stake of 1,106 shares — an estimated $288K sold.

ProShare Advisors first reported a position in AXDX in Q1 2014 and held it in 2 quarters. The position peaked at $288K in Q2 2014. 71 funds tracked by Wall St. Rank hold AXDX as of Q3 2014.

  • ProShare Advisors reported no remaining Accelerate Diagnostics position as of Q3 2014 after selling out during the quarter.
  • ProShare Advisors sold 1,106 Accelerate Diagnostics shares in Q3 2014, an estimated $288K.
  • ProShare Advisors first reported a position in Accelerate Diagnostics in Q1 2014 and held it in 2 quarters.
  • ProShare Advisors's Accelerate Diagnostics position peaked at $288K in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2014.

Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.